Molecular heterogeneity of cytosolic forms of estrogen receptors from human breast tumors.

Abstract Molecular heterogeneity of estrogen receptors in cytosols from human breast carcinomas was demonstrated with regard to size and surface ionic charge. Following separation of the molecular forms of estrogen receptors into either the 8S or the 4S species by sedimentation on linear gradients of sucrose, diethylaminoethyl cellulose chromatography was used to fractionate the various components in these receptors. Separation of the 8S species by diethylaminoethyl cellulose chromatography revealed a number of specific binding components, each eluting at a different ionic strength. The number of components as well as their relative specific estrogen-binding capacities were highly varible. At least five different species were identified on the basis of their elution at different ionic strengths. Estrogen-binding components eluted either in the wash buffer or at a KCI concentration of 0.02 to 0.05, 0.13 to 0.17, 0.18 to 0.21, or >0.3 m. The 4S form of the estrogen receptor separated into at least two components, each eluting at a different ionic strength. Clinical correlations of objective remissions in breast cancer patients given hormonal therapy with the molecular species of estrogen receptors indicated that women with tumors containing the 8S form showed a greater likelihood of responding. Our findings with diethylaminoethyl cellulose chromatography suggest that the molecular composition of the 8S species of estrogen receptors from hormonally responsive tumors is different from that of certain uresponsive neoplasms.

[1]  H. Rochefort,et al.  Nuclear translocation of the estrogen receptor in autonomous C3H mouse mammary tumors. , 1978, Cancer research.

[2]  J. Wittliff,et al.  Assessment of "activation" of estrogen receptors in lactating mammary gland using DNA-cellulose binding. , 1977, Biochemical and biophysical research communications.

[3]  J. Wittliff,et al.  Characteristics of progesterone-binding components in neoplastic mammary tissues of the rat. , 1976, Cancer research.

[4]  D. Gardner,et al.  Specific estrogen receptors in the lactating mammary gland of the rat. , 1973, Biochemistry.

[5]  A. Pihl,et al.  Content of estrogen receptors in human breast cancer. , 1973, European journal of cancer.

[6]  G. Shyamala Estradiol receptors in mouse mammary tumors: absence of the transfer of bound estradiol from the cytoplasm to the nucleus. , 1972, Biochemical and biophysical research communications.

[7]  E. Jensen,et al.  Estrogen receptors and breast cancer response to adrenalectomy. , 1971, National Cancer Institute monograph.

[8]  T. Aoyagi,et al.  Leupeptins, new protease inhibitors from Actinomycetes. , 1969, The Journal of antibiotics.

[9]  L. Miller,et al.  Mero-receptors: proteolytic fragments of receptors containing the steroid-binding site. , 1978, Federation proceedings.

[10]  K. Calman,et al.  Nuclear oestrogen receptors and treatment of breast cancer. , 1977, Lancet.

[11]  J. Wittliff,et al.  Estrogen receptors and hormone dependency in human breast cancer. , 1976, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[12]  W. McGuire Estrogen receptors in human breast cancer. , 1973, The Journal of clinical investigation.

[13]  P. Brecher,et al.  Hormone-receptor interaction as a guide to biochemical mechanism. , 1971, Biochemical Society symposium.